Indian J Pharm Close
 

Figure 2: Schematic view of the main aberrant signaling pathways in T-ALL and the potential molecular targets for therapy

Figure 2: Schematic view of the main aberrant signaling pathways in T-ALL and the potential molecular targets for therapy